Trials / Completed
CompletedNCT02667470
Reproducibility Study of OABSS and Its Response to Treatment
Overactive Bladder Symptom Scores (OABSS) Responsiveness Before and After Anticholinergic Treatment in Women With Overactive Bladder (OAB)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate change of Overactive Bladder (OAB) Symptom Score (OABSS) scores between before and after Solifenacin treatment to OAB patients and to evaluate correlation between change of OABSS scores and other measures for OAB symptoms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Solifenacin | Oral |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2013-05-01
- Completion
- 2013-05-01
- First posted
- 2016-01-29
- Last updated
- 2016-01-29
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT02667470. Inclusion in this directory is not an endorsement.